To this end, the terms ‘riboflavin transporter deficiency, type 1 (hRFT1), 2 (hRFT2) and 3 (hRFT3)’ were recommended (Bosch et al., 2012). The gene discussed is SLC52A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.